CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2020
Cash flows from operating activities:
Net loss	$ (326,361)	$ (98,720)	$ (31,091)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Stock-based compensation	197,157	68,290	18,064
Amortization of intangible assets	75,977	5,659	0
Depreciation and amortization	9,161	4,443	3,233
Amortization of capitalized internal-use software costs	2,366	907	1,024
Amortization of debt discount (accretion of debt premium) and issuance costs	4,777	27,531	0
Amortization of premium (accretion of discount) on investments in marketable debt securities	11,386	4,692	(3,815)
Provision for losses on acquired card receivables	19,879	741	0
Non-cash operating lease expense	8,601	3,813	0
Deferred income taxes	(4,075)	(40,617)	0
Other	(726)	0	717
Changes in assets and liabilities:
Accounts receivable	(3,032)	(6,535)	(1,608)
Prepaid expenses and other current assets	(12,970)	706	(10,434)
Other assets	5,105	(12,525)	(4,928)
Accounts payable	(3,771)	7,417	(1,596)
Other accruals and current liabilities	7,460	22,980	9,755
Operating lease liabilities	(7,877)	8,395	0
Other long-term liabilities	(6,749)	592	12,991
Deferred revenue	5,599	6,854	3,258
Net cash (used in) provided by operating activities	(18,093)	4,623	(4,430)
Cash flows from investing activities:
Cash paid for acquisition, net of acquired cash and cash equivalents	(144,349)	(556,090)	0
Purchases of corporate and customer fund short-term investments	(2,801,697)	(2,070,296)	(1,088,611)
Proceeds from maturities of corporate and customer fund short-term investments	1,902,474	1,104,532	806,000
Proceeds from sale of corporate and customer fund short-term investments	55,744	142,665	46,159
Increase in acquired card receivables and other	(130,537)	(26,495)	(959)
Purchases of property and equipment	(5,377)	(18,902)	(11,437)
Capitalization of internal-use software costs	(10,259)	(2,304)	(639)
Proceeds from beneficial interest	6,699	0	0
Net cash used in investing activities	(1,127,302)	(1,426,890)	(249,487)
Cash flows from financing activities:
Proceeds from issuance of common stock upon public offering, net of underwriting discounts and other offering costs	1,341,122	0	0
Proceeds from issuance of convertible senior notes, net of discounts and issuance costs	560,075	1,129,379	0
Purchase of capped calls	(37,893)	(87,860)	0
Proceeds from issuance of common stock upon initial public offering, net of underwriting discounts and commissions and other offering costs	0	0	225,481
Proceeds from issuance of common stock upon follow-on public offering, net of underwriting discounts and commissions and other offering costs	0	0	308,176
Increase in customer fund deposits liability and other	970,889	563,291	314,937
Proceeds from line of credit borrowings	37,500	0	2,300
Payments on line of credit and bank borrowings	(40,000)	(2,300)	0
Proceeds from exercise of stock options	34,024	28,209	12,232
Proceeds from issuance of common stock under the employee stock purchase plan	12,849	8,864	0
Net cash provided by financing activities	2,878,566	1,639,583	863,126
Effect of exchange rate changes on cash, cash equivalents, restricted cash, and restricted cash equivalents	(149)	0	0
Net increase in cash, cash equivalents, restricted cash, and restricted cash equivalents	1,733,022	217,316	609,209
Cash, cash equivalents, restricted cash, and restricted cash equivalents, beginning of year	1,809,693	1,592,377	983,168
Cash, cash equivalents, restricted cash, and restricted cash equivalents, end of year	3,542,715	1,809,693	1,592,377
Reconciliation of cash, cash equivalents, restricted cash, and restricted cash equivalents within the consolidated balance sheets to the amounts shown in the consolidated statements of cash flows above:
Cash and cash equivalents	1,596,542	509,615	573,643
Restricted cash included in other current assets	85,252	10,977	35
Restricted cash included in other assets	6,724	6,875	0
Restricted cash and restricted cash equivalents included in funds held for customers	1,854,197	1,282,226	1,018,699
Total cash, cash equivalents, restricted cash, and restricted cash equivalents, end of year	3,542,715	1,809,693	1,592,377
Supplemental disclosure of cash flow information:
Cash paid for interest	4,867	112	174
Noncash investing and financing activities:
Fair value of shares issued as consideration for acquisition	488,494	1,603,543	0
Fair value of stock-based awards assumed in acquisition	21,724	55,275	0
Recognition of beneficial interest	4,690	0	0
Payable on purchases of property and equipment	1,936	664	0
Conversion of redeemable convertible preferred stock into common stock upon initial public offering	0	0	276,307
Reclassification of redeemable convertible preferred stock warrant liabilities into additional paid-in capital upon initial public offering	0	0	1,405
Receivable from broker-assisted exercises of stock options	0	0	1,228
Accrued stock and debt issuance costs	$ 0	$ 120	$ 664